Novel Data Sharing Between a Comprehensive Cancer Center and a Private Payer to Better Understand Care at the End of Life  Sherri O. Stuver, ScD, Kristen McNiff, MPH, Bélen Fraile, MD, MPH, Oreofe Odejide, MD, MPH, Gregory A. Abel, MD, MPH, Anton Dodek, MD, Joseph O. Jacobson, MD, MSc  Journal of Pain and Symptom Management  Volume 52, Issue 2, Pages 161-169 (August 2016) DOI: 10.1016/j.jpainsymman.2016.02.004 Copyright © 2016 American Academy of Hospice and Palliative Medicine Terms and Conditions

Fig. 1 Distribution of end-of-life outcomes based on whether the patient received care at Dana-Farber Cancer Institute (DFCI) or an affiliated hospital, shown by the blue bars, versus outside of those institutions, the red bars. Emergency department (ED) visits, hospitalizations, intensive care unit (ICU) admissions, radiation therapy use, and undergoing a surgical procedure were assessed in the last 30 days of life; receipt of chemotherapy was assessed in the last 14 days of life. Journal of Pain and Symptom Management 2016 52, 161-169DOI: (10.1016/j.jpainsymman.2016.02.004) Copyright © 2016 American Academy of Hospice and Palliative Medicine Terms and Conditions